Tali Feferman

1.4k citations
34 papers · 1.0k indexed · h-index 18
Topics
Myasthenia Gravis and Thymoma (18 papers)Monoclonal and Polyclonal Antibodies Research (15 papers)T-cell and B-cell Immunology (10 papers)

In The Last Decade

Tali Feferman

34 papers receiving 1.0k citations

Peers

Tali Feferman
Comparison fields: 5 of 73
  • Immunology 387
  • Neurology 310
  • Molecular Biology 301
  • Oncology 210
  • Infectious Diseases 127
Replace Jian Rong Sheng with:
Jian Rong Sheng United States
Mahdia Benkhoucha Switzerland
Robert Medaer Belgium
Klaus‐Dieter Preuss Germany
Kevin R. Leiby United States
Jodi L. Karnell United States
Ali Chahlavi United States
Tone Berge Norway
Yonghao Cao United States
Kensuke Oikawa Japan
Tali Feferman relative to Jian Rong Sheng United States Jian Rong Sheng's profile →
Citations per field
00.5×3.8×
Jian Rong Sheng · 1×
Citations per year

Countries citing papers authored by Tali Feferman

Since Specialization
Citations

This map shows the geographic impact of Tali Feferman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tali Feferman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tali Feferman more than expected).

Fields of papers citing papers by Tali Feferman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tali Feferman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tali Feferman. The network helps show where Tali Feferman may publish in the future.

Co-authorship network of co-authors of Tali Feferman

This figure shows the co-authorship network connecting the top 25 collaborators of Tali Feferman. A scholar is included among the top collaborators of Tali Feferman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tali Feferman. Tali Feferman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 28
2 53
3 33
4 12
5 25
6 135
7 78
8 10
9 36
10 18
11 22
12 10
13 7
14 8
15 28
16 76
17 39
18 16
19 10
20 6

About Tali Feferman

Tali Feferman is a scholar working on Neurology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 34 papers that have together received 1.0k indexed citations. Recurring topics across this work include Myasthenia Gravis and Thymoma (18 papers), Monoclonal and Polyclonal Antibodies Research (15 papers) and T-cell and B-cell Immunology (10 papers). The work is most often cited by research in Neurology (310 citations), Immunology (387 citations) and Oncology (210 citations). Tali Feferman has collaborated with scholars based in Israel, France and United States. Frequent co-authors include Sara Fuchs, Miriam C. Souroujon, Revital Aricha, Guy Shakhar, Prasanta Kumar Maiti, Sonia Berrih‐Aknin, Avner Yayon, R Adar, Orit Segev and Efrat Monsonego‐Ornan. Their work appears in journals such as The Journal of Immunology, PLoS ONE and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026